These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 17695713)
1. An integrated approach to developing chemoenzymatic processes at the industrial scale. Tao J; Zhao L Ernst Schering Found Symp Proc; 2006; (3):117-31. PubMed ID: 17695713 [TBL] [Abstract][Full Text] [Related]
2. Advances in biocatalytic synthesis of pharmaceutical intermediates. Panke S; Wubbolts M Curr Opin Chem Biol; 2005 Apr; 9(2):188-94. PubMed ID: 15811804 [TBL] [Abstract][Full Text] [Related]
3. Biocatalysis in drug discovery and development. Fryszkowska A; Devine PN Curr Opin Chem Biol; 2020 Apr; 55():151-160. PubMed ID: 32169795 [TBL] [Abstract][Full Text] [Related]
4. Biocatalysis for pharmaceutical intermediates: the future is now. Pollard DJ; Woodley JM Trends Biotechnol; 2007 Feb; 25(2):66-73. PubMed ID: 17184862 [TBL] [Abstract][Full Text] [Related]
5. Enzymes in the synthesis of chiral drugs. Margolin AL Enzyme Microb Technol; 1993 Apr; 15(4):266-80. PubMed ID: 7763611 [TBL] [Abstract][Full Text] [Related]
6. New opportunities for biocatalysis: making pharmaceutical processes greener. Woodley JM Trends Biotechnol; 2008 Jun; 26(6):321-7. PubMed ID: 18436317 [TBL] [Abstract][Full Text] [Related]
7. Chemoenzymatic synthesis of small molecule human therapeutics. Ran N; Rui E; Liu J; Tao J Curr Pharm Des; 2009; 15(2):134-52. PubMed ID: 19149609 [TBL] [Abstract][Full Text] [Related]
8. Synthesizing Chiral Drug Intermediates by Biocatalysis. Jiang W; Fang B Appl Biochem Biotechnol; 2020 Sep; 192(1):146-179. PubMed ID: 32323141 [TBL] [Abstract][Full Text] [Related]
9. Biocatalytic routes to chiral amines and amino acids. Gotor-Fernández V; Gotor V Curr Opin Drug Discov Devel; 2009 Nov; 12(6):784-97. PubMed ID: 19894190 [TBL] [Abstract][Full Text] [Related]
11. Integrated operation of continuous chromatography and biotransformations for the generic high yield production of fine chemicals. Bechtold M; Makart S; Heinemann M; Panke S J Biotechnol; 2006 Jun; 124(1):146-62. PubMed ID: 16516996 [TBL] [Abstract][Full Text] [Related]
13. Hybrid schemes based on quantum mechanics/molecular mechanics simulations goals to success, problems, and perspectives. Ferrer S; Ruiz-Pernía J; Martí S; Moliner V; Tuñón I; Bertrán J; Andrés J Adv Protein Chem Struct Biol; 2011; 85():81-142. PubMed ID: 21920322 [TBL] [Abstract][Full Text] [Related]
14. Industrial biotransformations in the synthesis of building blocks leading to enantiopure drugs. Muñoz Solano D; Hoyos P; Hernáiz MJ; Alcántara AR; Sánchez-Montero JM Bioresour Technol; 2012 Jul; 115():196-207. PubMed ID: 22230779 [TBL] [Abstract][Full Text] [Related]
15. On the development of new biocatalytic processes for practical pharmaceutical synthesis. Huisman GW; Collier SJ Curr Opin Chem Biol; 2013 Apr; 17(2):284-92. PubMed ID: 23462589 [TBL] [Abstract][Full Text] [Related]
16. Exploring substrate binding and discrimination in fructose1, 6-bisphosphate and tagatose 1,6-bisphosphate aldolases. Zgiby SM; Thomson GJ; Qamar S; Berry A Eur J Biochem; 2000 Mar; 267(6):1858-68. PubMed ID: 10712619 [TBL] [Abstract][Full Text] [Related]
17. Biocatalysis: A smart and green tool for the preparation of chiral drugs. Rossino G; Robescu MS; Licastro E; Tedesco C; Martello I; Maffei L; Vincenti G; Bavaro T; Collina S Chirality; 2022 Nov; 34(11):1403-1418. PubMed ID: 35929567 [TBL] [Abstract][Full Text] [Related]
18. New emerging bio-catalysts design in biotransformations. Palomo JM; Filice M Biotechnol Adv; 2015; 33(5):605-13. PubMed ID: 25560932 [TBL] [Abstract][Full Text] [Related]
19. Stereodivergent Evolution of Artificial Enzymes for the Michael Reaction. Garrabou X; Macdonald DS; Wicky BIM; Hilvert D Angew Chem Int Ed Engl; 2018 May; 57(19):5288-5291. PubMed ID: 29446221 [TBL] [Abstract][Full Text] [Related]